The abstract is read at the publisher; the summary is JClub's.
T-cell-specific Rock2 deletion in mice in a 21-day deoxycorticosterone acetate-salt hypertension model attenuates hypertensive responses and protects against cardiac and aortic fibrosis.
- Why it matters: Even when blood pressure is controlled, hypertension still links to unresolved inflammation and end-organ injury, creating a need for immune-modulating adjunct therapies.
- What they did: In T-cell-specific Rock2 knockout mice (Rock2 fl/fl CD4 Cre+) versus littermate controls, investigators measured blood pressure, cardiac fibrosis, renal injury, and immune-cell infiltration; they also treated wild-type mice with KD025/belumosudil (50 mg/kg per day) starting after day 10.
- The result: KD025/belumosudil did not reduce blood pressure, but it decreased T helper 17 polarization, increased the cardiac regulatory T cells/T helper 17 ratio, reduced cardiac and aortic fibrosis, improved hemodynamic and echocardiographic indices, and attenuated albuminuria and renal T-cell infiltration.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.